We are live on ! Find out more
IART icon

Integra LifeSciences

236 hedge funds and large institutions have $2.88B invested in Integra LifeSciences in 2017 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 95 increasing their positions, 73 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

87% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 23

30% more repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 73

6% more funds holding

Funds holding: 223236 (+13)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

3% less capital invested

Capital invested by funds: $2.96B → $2.88B (-$86M)

66% less call options, than puts

Call options by funds: $653K | Put options by funds: $1.92M

94.42% less ownership

Funds ownership: 185.69%91.27% (-94%)

Holders
236
Holders Change
+13
Holders Change %
+5.83%
% of All Funds
5.88%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
43
Increased
95
Reduced
73
Closed
23
Calls
$653K
Puts
$1.92M
Net Calls
-$1.27M
Net Calls Change
-$11.2M
Name Holding Trade Value Shares
Change
Change in
Stake
TPSF
101
Texas Permanent School Fund
Texas
$1.82M -$14.9K -348 -0.8%
Public Sector Pension Investment Board (PSP Investments)
102
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.82M +$42.7K +1,000 +2%
MLICM
103
Metropolitan Life Insurance Company (MetLife)
New York
$1.76M
UBS AM
104
UBS AM
Illinois
$1.68M -$233K -5,449 -12%
RFC
105
Regions Financial Corp
Alabama
$1.63M +$1.65M +38,646 New
FNBOO
106
First National Bank of Omaha
Nebraska
$1.62M +$353K +8,255 +27%
Susquehanna International Group
107
Susquehanna International Group
Pennsylvania
$1.61M -$5.19M -121,576 -76%
SCM
108
Stevens Capital Management
Pennsylvania
$1.58M +$1.6M +37,479 New
HCM
109
Highbridge Capital Management
New York
$1.55M +$1.58M +36,865 New
AIG
110
American International Group
New York
$1.54M -$327K -7,646 -17%
First Trust Advisors
111
First Trust Advisors
Illinois
$1.53M +$50.5K +1,182 +3%
ERSOT
112
Employees Retirement System of Texas
Texas
$1.52M
GAM
113
Gotham Asset Management
New York
$1.47M +$486K +11,375 +49%
Thrivent Financial for Lutherans
114
Thrivent Financial for Lutherans
Minnesota
$1.42M +$69.2K +1,620 +5%
ASRS
115
Arizona State Retirement System
Arizona
$1.31M +$12.8K +300 +1%
AIM
116
Assured Investment Management
New York
$1.3M +$1.32M +30,953 New
AQR Capital Management
117
AQR Capital Management
Connecticut
$1.22M -$200K -4,676 -14%
CC
118
Cipher Capital
New York
$1.21M +$1.22M +28,617 New
State Board of Administration of Florida Retirement System
119
State Board of Administration of Florida Retirement System
Florida
$1.2M
FRM
120
Fox Run Management
Connecticut
$1.18M +$1.2M +28,000 New
AG
121
Advisor Group
Arizona
$1.18M -$3.5K -82 -0.3%
VKH
122
Virtu KCG Holdings
New York
$1.17M +$347K +8,132 +42%
DCM
123
Driehaus Capital Management
Illinois
$1.13M +$1.15M +26,897 New
NBC
124
Neuberger Berman Canada
Ontario, Canada
$1.12M +$608K +14,231 +115%
IPC
125
Independent Portfolio Consultants
Florida
$1.07M +$51.3K +1,200 +5%

IART Hedge Fund Activity: Q1 2017 in Review

236 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q1 2017, worth a combined $2.88B — down 2.9% from $2.96B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new IART positions and 23 closed out — a net gain of 20 holders — while 95 added to existing stakes and 73 trimmed.

The largest buyer was BlackRock, adding an estimated $318M. The largest seller was Fidelity Investments, cutting an estimated $126M.

  • 236 institutional investors held Integra LifeSciences (IART) as of Q1 2017, up from 223 in Q4 2016.
  • Funds reported $2.88B of Integra LifeSciences stock for Q1 2017, down 2.9% quarter-over-quarter.
  • 43 funds opened new Integra LifeSciences positions in Q1 2017 and 23 closed out, a net change of +20 holders.
  • The largest Integra LifeSciences buyer in Q1 2017 was BlackRock, an estimated $318M added.
  • The largest Integra LifeSciences seller in Q1 2017 was Fidelity Investments, an estimated $126M sold.

Based on aggregated 13F filings for Q1 2017.